CHOP researchers named to TIME100 list for patient-tailored gene editing therapy
Two researchers from Children’s Hospital of Philadelphia have been named to the 2026 TIME100 list after pioneering patient-tailored CRISPR gene editing therapy. Their work marks progress toward new treatments for rare diseases previously considered untreatable.








